Infectious disease and vaccine development
4 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- JUSTUS-LIEBIG-UNIVERSITAET GIESSEN
German research university strong in visual perception, RNA biology, infectious disease, space propulsion, and African agricultural development.
“Coordinated SPARk on malaria transmission; participated in CCHFVaccine, OPENCORONA, MAD-CoV 2, and ALKATRAS covering zoonotic viruses, COVID-19, and cancer.”
DE33 projects - INSERM TRANSFERT SA
Technology transfer arm of France's INSERM, managing IP and clinical translation across infectious disease, neurodegeneration, and precision medicine consortia.
“EBOVAC2 and CCHFVaccine (vaccine programs), EHVA (HIV vaccines), CARE and EU-RESPONSE (COVID-19), VHFMoDRAD and EbolaMoDRAD (rapid diagnostics), ZIKAlliance (Zika prevention).”
PrimaryFR33 projects - GENOME RESEARCH LIMITED LBG
World-leading genomics institute providing industrial-scale sequencing, single-cell transcriptomics, and computational biology for human disease research across Europe.
“Contributed genomics expertise to OptiMalVax and MultiViVax (malaria), COMPARE (foodborne outbreaks), and EAVI2020 (AIDS vaccine).”
UK27 projects - THE UNIVERSITY OF WESTERN ONTARIO
Canadian research university contributing international expertise in life sciences, digital health, and governance to EU consortia as a third-party partner.
“EAVI2020 was a large European AIDS Vaccine Initiative consortium where UWO contributed as a participant.”
CA7 projects